E-mail: info@norpen.org

NorPEN is a network of researcher groups with the aim of facilitating research within the field of pharmacoepidemiology in the Nordic countries.

May 15, 2024

Application for membership

Nordic research groups with an interest in pharmacoepidemiology can apply for membership in NorPEN. Please see the NorPEN by-laws for eligibility criteria.

A completed application form can be sent to the Executive Committee representative for the country where the research group is based. The application should be sent by the research group leader or designate with mandate to represent the research group.

Applications for memberships will be evaluated by the Executive Committee at the next meeting (held once per month).

Decisions on membership are forwarded to the applicant by the NorPEN chair.

[Download NorPEN by-laws]

Current NorPEN Member Groups

Research groups

  • Pharmacovigilance Research Center, University of Copenhagen [Web]
  • Pharmacoepidemiological research group at University of Southern Denmark [Web]
  • Department of Clinical Epidemiology at Aarhus University Hospital, Aarhus [Web]
  • Department of Epidemiology Research, Statens Serum Institut [Web]

  • Finland
  • Helsinki University Pharmacoepidemiology [Web]
  • Drugs and Pregnancy, Institute for Health and Welfare [Web]
  • Psychiatric Pharmacoepidemiology Research Group, Niuvanniemi Hospital, Kuopio
  • Kela Research at the Social Insurance Institution, Finland [Web]
  • Beneficial and harmful effects of antipsychotics in on- and off label use Oulu University [ Web]
  • Information and development services, Finnish Medicines Agency [Web]
  • Team Real-world Evidence, School of Pharmacy, University of Eastern Finland [Web]

  • Iceland
  • Faculty of Pharmaceutical Sciences, University of Iceland [Web]

  • Norway
  • Medicines and patient safety at Oslo Metropolitan University (former Oslo and Akershus university college of Applied sciences) [Web]
  • PharmacoEpidemiology and Drug Safety (Pharma-Safe), School of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo [Web]
  • Department of Chronic Diseases, Norwegian Institute of Public Health [Web]
  • Research group clinical pharmacy/pharmacoepidemiology, Department of Pharmacy, The Arctic University of Norway [Web]

  • Sweden
  • The Centre for Pharmacoepidemiology (CPE) at Karolinska Institutet, Stockholm [Web]
  • Pharmacoepidemiology Research Group, Division of Clinical Epidemiology, Karolinska Institutet, Stockholm [Web]
  • MEDUP - Medicine Use and Pharmaceutical Polity, University of Gothenburg [Web]
  • The research group of psychiatric epidemiology at the Department of Medical Epidemiology and Biostatistics at Karolinska Institutet [Web] and ADHD research team at �rebro University [Web]
  • Swedish Medical Products Agency, Department of Pharmacoepidemiology and Analysis [Web]
  • CAUSALab at KI, Institute of Environmental Medicine, Karolinska Institute [Web]
  • Division of Clinical Pharmacology, Karolinska Institutet [Web]
  • Pharmacoepidemiology Research Group, Faculty of Pharmacy, Uppsala University [Web]
  • The research group of Geriatric Pharmacoepidemiology at the Department of Medical Epidemiology and Biostatistics at Karolinska Institutet [Web]

  • Register holders

  • The Social Insurance Institution, Finland [Web]
  • The Register for Medicinal Product Statistics, The Danish Health Data Authority, Denmark [Web]
  • Norwegian Prescribed Drug Registry, Norway [Web]
  • Finnish Institute for Health and Welfare, Finland [Web]
  • National Board of Health and Welfare, Sweden [Web]

  • National Societies

  • Dansk Selskab for Farmakoepidemiologi (DSFE) / Danish Society for Pharmacoepidemiology [Web]

  • Finland
  • Suomen Epidemiologian Seura (FES) / Finnish Epidemiology Society [Web]

  • Norway
  • Norsk forening for farmakoepidemiologi (DURG Norge) / Norwegian Society for Pharmacoepidemiology [Web]